Outset Medical (OM) Competitors $16.90 -0.64 (-3.65%) Closing price 04:00 PM EasternExtended Trading$17.00 +0.10 (+0.59%) As of 05:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock OM vs. ESTA, BLFS, TNDM, PLSE, MDXG, INMD, KMTS, SIBN, IRMD, and EMBCShould you be buying Outset Medical stock or one of its competitors? The main competitors of Outset Medical include Establishment Labs (ESTA), BioLife Solutions (BLFS), Tandem Diabetes Care (TNDM), Pulse Biosciences (PLSE), MiMedx Group (MDXG), InMode (INMD), Kestra Medical Technologies (KMTS), SiBone (SIBN), iRadimed (IRMD), and Embecta (EMBC). These companies are all part of the "medical equipment" industry. Outset Medical vs. Its Competitors Establishment Labs BioLife Solutions Tandem Diabetes Care Pulse Biosciences MiMedx Group InMode Kestra Medical Technologies SiBone iRadimed Embecta Outset Medical (NASDAQ:OM) and Establishment Labs (NASDAQ:ESTA) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, valuation, profitability, institutional ownership, media sentiment, analyst recommendations, risk and dividends. Is OM or ESTA more profitable? Establishment Labs has a net margin of -52.34% compared to Outset Medical's net margin of -98.74%. Outset Medical's return on equity of -143.62% beat Establishment Labs' return on equity.Company Net Margins Return on Equity Return on Assets Outset Medical-98.74% -143.62% -37.50% Establishment Labs -52.34%-196.25%-26.64% Do analysts prefer OM or ESTA? Outset Medical presently has a consensus price target of $29.50, suggesting a potential upside of 74.56%. Establishment Labs has a consensus price target of $54.83, suggesting a potential upside of 30.68%. Given Outset Medical's stronger consensus rating and higher probable upside, research analysts plainly believe Outset Medical is more favorable than Establishment Labs.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Outset Medical 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.00Establishment Labs 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.83 Do institutionals & insiders have more ownership in OM or ESTA? 72.9% of Establishment Labs shares are held by institutional investors. 2.4% of Outset Medical shares are held by insiders. Comparatively, 11.4% of Establishment Labs shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Does the media favor OM or ESTA? In the previous week, Establishment Labs had 3 more articles in the media than Outset Medical. MarketBeat recorded 7 mentions for Establishment Labs and 4 mentions for Outset Medical. Outset Medical's average media sentiment score of 0.93 beat Establishment Labs' score of 0.78 indicating that Outset Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Outset Medical 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Establishment Labs 2 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has better earnings and valuation, OM or ESTA? Establishment Labs has higher revenue and earnings than Outset Medical. Establishment Labs is trading at a lower price-to-earnings ratio than Outset Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOutset Medical$113.69M2.63-$127.98M-$29.15-0.58Establishment Labs$166.02M7.31-$84.60M-$3.10-13.54 Which has more risk and volatility, OM or ESTA? Outset Medical has a beta of 2.15, meaning that its share price is 115% more volatile than the S&P 500. Comparatively, Establishment Labs has a beta of 0.8, meaning that its share price is 20% less volatile than the S&P 500. SummaryEstablishment Labs beats Outset Medical on 10 of the 17 factors compared between the two stocks. Get Outset Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for OM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding OM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OM vs. The Competition Export to ExcelMetricOutset MedicalMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$299.47M$2.11B$5.59B$9.53BDividend YieldN/AN/A4.71%4.03%P/E Ratio-0.5837.9527.9719.94Price / Sales2.6327.95389.6466.03Price / CashN/A56.0636.3258.75Price / Book2.269.138.345.77Net Income-$127.98M-$63.64M$3.25B$259.19M7 Day Performance-13.07%-5.98%-2.50%-3.41%1 Month Performance-12.02%6.79%7.97%8.53%1 Year Performance-67.90%4.37%34.58%15.74% Outset Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OMOutset Medical1.3116 of 5 stars$16.90-3.6%$29.50+74.6%-68.1%$299.47M$113.69M-0.58520News CoverageUpcoming EarningsHigh Trading VolumeESTAEstablishment Labs2.119 of 5 stars$42.48+0.2%$54.83+29.1%-12.4%$1.23B$170.24M-13.701,018BLFSBioLife Solutions2.2549 of 5 stars$22.23-1.6%$31.00+39.5%-7.1%$1.08B$82.25M-76.65440Positive NewsTNDMTandem Diabetes Care4.2071 of 5 stars$16.84+6.0%$32.71+94.3%-55.2%$1.06B$940.20M-6.062,650Positive NewsUpcoming EarningsPLSEPulse Biosciences3.7396 of 5 stars$15.21+1.9%$22.00+44.6%-2.8%$1.00B$700K0.00140News CoverageMDXGMiMedx Group3.5815 of 5 stars$6.79+0.3%$11.50+69.4%-12.5%$999.94M$352.38M25.15870News CoverageEarnings ReportINMDInMode3.2259 of 5 stars$14.54-1.2%$18.54+27.5%-20.5%$930.44M$394.82M6.24480News CoverageEarnings ReportAnalyst ForecastGap DownKMTSKestra Medical Technologies1.5543 of 5 stars$16.50-0.3%$27.33+65.7%N/A$849.82M$59.81M0.00300Positive NewsSIBNSiBone3.9558 of 5 stars$17.60+2.0%$22.50+27.8%+17.8%$735.10M$167.18M-27.50350Upcoming EarningsIRMDiRadimed4.6675 of 5 stars$57.11+1.4%$72.00+26.1%+23.7%$716.11M$73.24M36.85110News CoverageUpcoming EarningsEMBCEmbecta4.7292 of 5 stars$11.33-3.4%$19.00+67.7%-31.4%$685.53M$1.12B12.592,100Positive News Related Companies and Tools Related Companies ESTA Competitors BLFS Competitors TNDM Competitors PLSE Competitors MDXG Competitors INMD Competitors KMTS Competitors SIBN Competitors IRMD Competitors EMBC Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OM) was last updated on 7/30/2025 by MarketBeat.com Staff From Our PartnersAI Frenzy Could Send ‘EarnPhone’ SoaringThe hidden fuel behind AI? Your phone. Billions of data points — from your clicks, swipes, scrolls, and sea...Mode Mobile | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredThe Fed Just Froze You Out (Again)The Fed’s holding rates steady—again. No clarity. No yield. No relief. But one income strategy is quietly t...Investors Alley | SponsoredOne stock to replace Nvidia"I said 'SELL' before this stock dropped 90%. Today, I'm shouting 'BUY NOW' before it's too late." In 2000,...InvestorPlace | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredSomething BIG is about to hit the stock marketMost investors won’t see it coming—but Weiss Ratings says a major market event is brewing. Their system jus...Weiss Ratings | SponsoredThe $1 Trillion Event Tesla Still Hasn’t Recovered FromIn 2010, a “Flash Crash” erased $1 trillion in minutes. Now, one trading legend says it’s happening again—insi...Brownstone Research | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Outset Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Outset Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
